ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Tennessee » Interventional Cardiology

Top Interventional Cardiology Prescribers in Tennessee

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SUNIL RAMAPRASAD M.D., F.A.C.C.

Interventional Cardiology

14,827

$725K

1704
1306 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $59

HARRY BISHOP M.D.

Interventional Cardiology

14,714

$1.01M

1010
768 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 25%

$69
Average prescription price

Avg: $59

CLINT DOIRON M.D.

Interventional Cardiology

12,126

$801K

896
736 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 25%

$66
Average prescription price

Avg: $59

HENRY LUI M.D.

Interventional Cardiology

11,481

$780K

804
692 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 25%

$68
Average prescription price

Avg: $59

RAJ DAVE MD

Interventional Cardiology

9,689

$421K

586
413 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 25%

$43
Average prescription price

Avg: $59

HAROLD ALISON MD

Interventional Cardiology

8,088

$561K

984
834 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 25%

$69
Average prescription price

Avg: $59

STEVEN REED M.D.

Interventional Cardiology

7,907

$485K

586
461 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $59

STEVEN STUBBLEFIELD M.D.

Interventional Cardiology

7,450

$533K

662
526 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 25%

$72
Average prescription price

Avg: $59

ALBERT BLACKY M.D.

Interventional Cardiology

6,991

$382K

723
600 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $59

VAFA MANSOURI D.O.

Interventional Cardiology

6,810

$281K

554
404 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 25%

$41
Average prescription price

Avg: $59

MOHAMED BASHAR SHALA MD

Interventional Cardiology

6,675

$353K

537
444 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $59

JOSEPH WEINSTEIN MD

Interventional Cardiology

6,608

$562K

645
522 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 25%

$85
Average prescription price

Avg: $59

STEPHEN HOADLEY M.D.

Interventional Cardiology

6,266

$296K

503
390 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 25%

$47
Average prescription price

Avg: $59

SUSAN SOUTHER M.D.

Interventional Cardiology

6,178

$315K

601
501 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $59

MARK CHANG MD

Interventional Cardiology

5,911

$298K

873
753 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $59

JOHN SCOTT MD

Interventional Cardiology

5,899

$475K

470
409 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 25%

$80
Average prescription price

Avg: $59

MILTON ADDINGTON MD

Interventional Cardiology

5,873

$355K

406
338 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $59

STACY SMITH MD

Interventional Cardiology

5,598

$308K

459
393 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $59

TAYLOR WEATHERBEE M.D.

Interventional Cardiology

5,407

$283K

449
365 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $59

ROGER RIEDEL M.D.

Interventional Cardiology

5,323

$308K

597
513 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $59

BARRY MICHELSON M.D.

Interventional Cardiology

4,952

$347K

465
348 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 25%

$70
Average prescription price

Avg: $59

GREGORY BREWER M.D.

Interventional Cardiology

4,882

$393K

408
322 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 25%

$80
Average prescription price

Avg: $59

STUART BRESEE M.D.

Interventional Cardiology

4,837

$324K

527
425 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 25%

$67
Average prescription price

Avg: $59

STEPHEN KIEFER M.D.

Interventional Cardiology

4,662

$239K

412
329 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $59

THOMAS AYRES MD

Interventional Cardiology

4,638

$238K

477
407 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $59

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank